---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-022823"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2026-05-14T01:08:16+00:00"
generated_at: "2026-05-14T10:14:29.423393+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Intelligent Bio Q3 revenue $1.06M (+46% YoY); cartridge sales up 59%

## Summary
- Q3 cartridge revenue $703,538, up 59% YoY, representing 66% of total sales.
- Gross profit margin expanded to 50.5% in Q3 (vs 46.8% prior year); nine-month margin 49.3%.
- Nine-month revenue reached $3.07M, up 39% YoY; cash balance $6.86M at March 31, 2026.
- Marketing spend in Q3 down 42% YoY while commercial momentum accelerated.
- FDA 510(k) program advancing; new manufacturing partnership and Bouygues UK customer added.

## SEC filing metadata
- accession: 0001493152-26-022823
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2026-05-14T01:08:16+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000149315226022823/0001493152-26-022823-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000149315226022823/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-022823
- JSON: https://secwatch.observer/filing/0001493152-26-022823.json
- Plain text: https://secwatch.observer/filing/0001493152-26-022823.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.